BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15242487)

  • 1. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis.
    Fujii T; Takayasu K; Muramatsu Y; Moriyama N; Wakao F; Kosuge T; Takayama T; Makuuchi M; Yamasaki S; Okazaki N
    Jpn J Clin Oncol; 1993 Apr; 23(2):105-9. PubMed ID: 8390584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
    Hiraoka A; Michitaka K; Horiike N; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Sogabe I; Ishimaru Y; Kawasaki H; Koizumi Y; Hirooka M; Yamashita Y; Abe M; Hiasa Y; Matsuura B; Onji M
    J Gastroenterol Hepatol; 2010 Feb; 25(2):403-7. PubMed ID: 19929922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection for hepatocellular carcinoma in elderly patients.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
    Cho SJ; Yoon JH; Hwang SS; Lee HS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the clinicopathological features of hepatocellular carcinoma in elderly patients.
    Jing-Lin X; Sharma D; Bing-Hui Y; Bo-Heng Z; Zeng-Chen M; Zhi-Quan W; Jia F; Xin ZD; Lun-Xiu Q; Zhao-You X
    JNMA J Nepal Med Assoc; 2008; 47(171):132-5. PubMed ID: 19079378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients.
    Trevisani F; D'Intino PE; Grazi GL; Caraceni P; Gasbarrini A; Colantoni A; Stefanini GF; Mazziotti A; Gozzetti G; Gasbarrini G; Bernardi M
    Cancer; 1996 Jun; 77(11):2223-32. PubMed ID: 8635088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J
    Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
    Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
    Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age.
    Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S
    Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.